What does commercial auto liability — year 3 mean?

This metric captures the loss development or financial performance data for the commercial auto liability segment in the third year of the policy cycle. It helps assess the stability of claims reserves as they age and move toward final settlement. This data is critical for evaluating the long-term profitability of the segment.

King Pharmaceuticals KG Commercial Auto Liability — Year 3

Other product segments

General Liability

13.1%—

European Hospital Liability

10.4%—

All other lines

2.7%—

International

2.7%—

Similar metrics at other companies

KMPRCommercial Automobile Insurance—Liability — Year 3

65.6%-3.5pp

CNACommercial Auto — Year 3

19.1%+0.7pp

UFCSCommercial automobile — Year 3

17.3%+0.4pp

UFCSCommercial other liability — Year 3

14.1%-0.7pp

KMPRCommercial Automobile Insurance—Physical Damage — Year 3

100%0.0pp

HIGCommercial automobile physical damage — 3rd Year

0.4%+0.3pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's commercial auto liability — year 3.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's commercial auto liability — year 3?: King Pharmaceuticals (KG) reported commercial auto liability — year 3 of 18.7% in Q4 2025.
What does commercial auto liability — year 3 mean?: This metric captures the loss development or financial performance data for the commercial auto liability segment in the third year of the policy cycle. It helps assess the stability of claims reserves as they age and move toward final settlement. This data is critical for evaluating the long-term profitability of the segment.